Amanda Malone, PhD (she/her/hers)

Eupraxia Pharmaceuticals, Canada

Poster(s):

• P2209 - Pharmacokinetics and Local Tolerability of EP-104GI, an Extended-Release Formulation of Fluticasone Propionate for Treatment of Eosinophilic Esophagitis, After Intra-Esophageal Injection in Mini-Pigs
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET